Dishman Of India Buys France’s Creapharm Parenterals For CRO Work
This article was originally published in PharmAsia News
Executive Summary
India’s Dishman Pharmaceuticals and Chemicals said it has acquired a unit of France’s Creapharm Group, Creapharm Parenterals.
India’s Dishman Pharmaceuticals and Chemicals said it has acquired a unit of France’s Creapharm Group, Creapharm Parenterals.
Dishman made the buy though its own subsidiary, Swiss-based Carbogen Amcis. The French unit is a contract development and manufacturing organization with specialties in liquid, semi-solid and injectable aseptic dosage forms for clinical trials. Financial details of the acquisition were not disclosed. (Click here for more)
Dishman Pharma Up 4% On French Firm Acquisition” – Business Standard (India) (1/17/12)